儿童重症监护室中毒患者的医学毒理学会诊与病死率
该研究为虚拟儿科系统(VPS)登记库的二次分析,纳入2019年1月至2023年6月美国135个医疗站点PICU收治的52 836例中毒暴露患者,其中2857例(5.4%)接受医学毒理学会诊。校正病情严重度、中毒类型等协变量后,会诊与PICU死亡风险降低64%(aOR 0.36;95%CI 0.20–0.63)、住院期间任何时点病死率降低61%(aOR 0.39;95%CI 0.24–0.64)相关。会诊还分别与PICU住院时间缩短15%(对数估计值-0.16;95%CI -0.21至-0.11)和住院时间缩短10%(对数估计值-0.10;95%CI -0.14至-0.06)相关。作者认为医学毒理学会诊可能提供挽救生命的治疗,尤其对PICU中最严重的中毒。
要点
- 52 836例PICU中毒暴露患者中仅2857例(5.4%)接受医学毒理学会诊,49 979例(94.6%)未会诊。
- 会诊组与未会诊组基线病死风险(按儿科死亡风险评分衡量)相似;校正后PICU死亡aOR 0.36(95%CI 0.20–0.63),住院病死aOR 0.39(95%CI 0.24–0.64)。
- 会诊与PICU住院时间缩短15%(对数估计值-0.16;95%CI -0.21至-0.11)及住院时间缩短10%(对数估计值-0.10;95%CI -0.14至-0.06)相关。
- 29 867例(56.5%)年龄12至<21岁,29 401例(55.6%)为女性。
适用人群与场景
- 2019年1月至2023年6月入住参与VPS数据库PICU的中毒暴露患者,数据来自美国135个医疗站点。
- 共52 836例,其中29 867例(56.5%)年龄12至<21岁,29 401例(55.6%)为女性。
研究设计与关键结果
- 研究类型:正在进行的横断面登记库(VPS)的二次分析,覆盖美国135个医疗站点,纳入2019年1月至2023年6月PICU收治的中毒暴露患者,数据分析于2024年5月至8月进行。
- 暴露:医学毒理学会诊;2857例(5.4%)接受会诊,49 979例(94.6%)未接受会诊;会诊组与未会诊组基线儿科死亡风险评分相似。
- 主要终点:校正病情严重度、中毒类型及其他协变量后,医学毒理学会诊与PICU死亡风险降低64%相关(aOR 0.36;95%CI 0.20–0.63),与住院期间任何时点病死率降低61%相关(aOR 0.39;95%CI 0.24–0.64)。
- 次要终点:校正所有协变量及院际差异后,会诊与PICU住院时间缩短15%相关(对数估计值-0.16;95%CI -0.21至-0.11),与住院时间缩短10%相关(对数估计值-0.10;95%CI -0.14至-0.06)。
证据类型、等级与局限
- 证据类型:基于VPS登记库的横断面研究二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在需要PICU救治的中毒暴露患者中,医学毒理学会诊可能提供挽救生命的治疗,尤其对PICU中最严重的中毒。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Poisonings are a leading cause of preventable mortality and morbidity among children. Pediatric poisonings are commonly managed in pediatric intensive care units (PICUs) and may require complex treatment and specialized evaluation. Physicians specializing in medical toxicology are trained to treat poisoned patients of all ages; however, they are not universally part of the medical staff across hospital systems.
OBJECTIVE: To determine if there is a difference in mortality and length of stay for patients with toxicological exposures who receive a medical toxicology consultation.
DESIGN, SETTING, AND PARTICIPANTS: This is a secondary analysis of an ongoing, cross-sectional registry of patients admitted to PICUs from January 2019 to June 2023 as part of the Virtual Pediatric System (VPS), a database of PICU admissions across 135 medical sites in the US. Patients with toxicological exposure who were admitted to PICUs that participate in the VPS database were included. Data analysis occurred from May to August 2024.
EXPOSURES: Medical toxicology consultations.
MAIN OUTCOMES AND MEASURES: The primary outcome was mortality in the PICU and in the hospital overall. Secondary outcomes were length of stay in the PICU and in the hospital. Multilevel models were used to assess associations of toxicology consultations with the primary and secondary outcomes.
RESULTS: There were a total of 52 836 patients with toxicological exposures (29 867 aged 12 to <21 years [56.5%]; 29 401 female [55.6%]), including 2857 (5.4%) patients with medical toxicology consultations and 49 979 (94.6%) without a consultation. Patients who received medical toxicology consultations had similar risk of mortality at baseline, as measured by the Pediatric Risk of Mortality, compared with those without consultations. After adjusting for severity of illness, poisoning type, and other covariates, medical toxicology consultations were associated with 64% lower odds of death in the PICU (adjusted odds ratio, 0.36; 95% CI, 0.20 to 0.63) and 61% lower odds of mortality at any time during the hospitalization (aOR, 0.39; 95% CI, 0.24 to 0.64). Additionally, medical toxicology consultations were associated with a 15% reduced PICU length of stay (log estimate, -0.16; 95% CI, -0.21 to -0.11) and 10% reduced hospital length of stay (log estimate, -0.10; 95% CI, -0.14 to -0.06) after adjusting for all covariates and differences across hospital sites.
CONCLUSIONS AND RELEVANCE: In this study of patients with toxicological exposures requiring PICU care, having a medical toxicology consultation was associated with lower mortality and shorter LOS compared with not having a consultation, which suggests that medical toxicology consultations may provide life-saving treatment, particularly for the most severe poisonings in the PICU.
参考来源
- Wax PM, Culbreth RE, Brent J, et al. Medical Toxicology Consultations and Mortality Among Patients With Poisonings in the PICU. JAMA Netw Open. 2025. PMID: 40019762. doi:10.1001/jamanetworkopen.2024.62139
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。